Dr. Larry J. Copeland, MD

Dr. Copeland practices at OSU GYN & OB Consultants in Hilliard, Ohio.

Dr. Copeland's NPI, 1477595510, was assigned on June 12, 2006. Dr. Copeland holds Ohio license 35056253.

Dr. Copeland's primary practice is OSU GYN & OB Consultants, at 3651 Ridge Mill Dr, Hilliard, OH 43026 in Franklin County. The practice phone is (614) 293-3069.

Dr. Copeland's primary practice is OSU GYN & OB Consultants in Hilliard, Ohio. Dr. Copeland is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Copeland to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Copeland practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Copeland's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Copeland is licensed in Ohio.

CMS data shows 243 Medicare services from Dr. Copeland across 3 procedure codes in 2024, all of them office visits, for 80 Medicare patients. Medicare paid $17,234 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Dr. Copeland in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Copeland's median patient age at 67, with 98% women.

In 2024, Dr. Copeland wrote 47 Medicare Part D claims for 15 patients. 45% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $196,399 in total drug cost. In 2021, CMS named 37 claims across 2 drugs.

Dr. Copeland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Copeland as offering telehealth.

Dmand AI links 42 papers to Dr. Copeland, published from 2019 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Carcinoma, Ovarian Epithelial. Dr. Copeland has published most often in Gynecol Oncol. Dr. Copeland's most frequent co-authors are Kristin Leigh Bixel, MD, Christa Irene Nagel, MD and Thomas John Herzog, MD.

Dmand AI links Dr. Copeland to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ovarian Neoplasms and Ovarian Diseases. Open Payments lists research payments to Dr. Copeland that name 1 trial.

CMS Open Payments shows 25 general payments to Dr. Copeland from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. TESARO, Inc. paid the most, $6,103. It also lists 2 research payments totaling $9,428 from 2016 to 2023, naming 1 clinical trial.